DLL4 and neoplasm: Numerous studies have proved that after blocking Dll4, despite the increase in tumor angiogenesis, the structural defects and poor perfusion will aggravate the degree of ischemia and hypoxia of tumor cells, and effectively inhibited the growth of tumors [23–26].